HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M J Morton Selected Research

N- (3- (1H- benzimidazol- 2- yl)- 4- chlorophenyl)pyridine- 3- carboxamide

6/2015Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M J Morton Research Topics

Disease

1Long QT Syndrome
06/2015
1Fibrosis (Cirrhosis)
09/2007
1Necrosis
09/2007
1Burns
02/2000

Drug/Important Bio-Agent (IBA)

1N- (3- (1H- benzimidazol- 2- yl)- 4- chlorophenyl)pyridine- 3- carboxamideIBA
06/2015
1DNA (Deoxyribonucleic Acid)IBA
09/2007
1SmokeIBA
02/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2007